AB569, Arch Biopartners’ lead therapy candidate, has received a U.S. patent for the treatment of chronic lung infections in patients with chronic obstructive pulmonary disease (COPD) or cystic fibrosis. Patent 9,925,206 was issued by the U.S. Patent and Trademark Office to the University of Cincinnati, which previously granted…
Treatment with Verona Pharma’s investigative drug RPL554 can effectively improve lung function in patients with chronic obstructive pulmonary disease (COPD), results from a Phase 2b trial showed. The trial (2016-005205-40) enrolled 403 patients with moderate-to-severe COPD from 45 centers in Europe. Participants were randomized to…
A 15-year study demonstrated how nontypeable Haemophilus influenzae (NTHi), one of the most important pathogens in chronic obstructive pulmonary disease (COPD), adapts and survives in patients’ airways over time. The research findings were reported in the journal Proceedings of the National Academy of Sciences, in a study titled “…
A mutation of the PDGFD gene is linked to an increased risk of adrenal gland suppression, a serious side effect of inhaled corticosteroids used to treat asthma and chronic obstructive pulmonary disease (COPD), researchers have found. The discovery, reported in the study, “Susceptibility to corticosteroid-induced adrenal suppression: a…
The long-term use of aspirin was found to reduce the severity of acute exacerbations in chronic obstructive pulmonary disease (AECOPD), including in-hospital mortality, invasive ventilation use, and hospital length-of-stay (LOS), researchers reported. The study, “The association of aspirin use with severity of acute exacerbation of chronic obstructive pulmonary disease:…
Survival in patients with chronic obstructive pulmonary disease (COPD) in need of lung transplantation might be considerably better than previously predicted, a new study recently published in the journal CHEST suggested. Because COPD is one of the leading indications for lung transplant — a third of all lung transplants are…
The American Lung Association is launching a joint effort with the National Urban League and the CVS Health Foundation aimed at reducing the smoking rate among African-Americans. The collaboration will provide free access to the American Lung Association’s proven smoking cessation program called “Freedom from Smoking” to…
Air pollution and other environmental factors have a greater impact on genes related to respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma than genetic ancestry, a new Canadian study shows. The research, “Gene-by-environment interactions in urban…
A new subset of stem cells was found to expand quickly after lung injury and to specifically restore the tissues of air sacs, called alveoli, according to a study published in the journal Nature. This finding can represent a new therapeutic option for treatments targeting pulmonary conditions such as…
Grifols, a global healthcare company, has launched the “Look into Genetic COPD” educational campaign to raise awareness of chronic obstructive pulmonary disease (COPD) that is caused by alpha-1-antitrypsin deficiency (alpha-1), a rare genetic condition. The global healthcare company, headquartered…
Get regular updates to your inbox.